The Worldwide Synthetic Biology Industry is Expected to Reach $34.2 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology Market Research Report by Tool (Chassis Organisms, Cloning Technology Kits, and Enzymes), Technology, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Synthetic Biology Market size was estimated at USD 16.95 billion in 2021, USD 19.01 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.41% to reach USD 34.21 billion by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Synthetic Biology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Synthetic Biology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Synthetic Biology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Synthetic Biology Market?

4. What is the competitive strategic window for opportunities in the Global Synthetic Biology Market?

5. What are the technology trends and regulatory frameworks in the Global Synthetic Biology Market?

6. What is the market share of the leading vendors in the Global Synthetic Biology Market?

7. What modes and strategic moves are considered suitable for entering the Global Synthetic Biology Market?

Market Dynamics

Drivers

• Rising R&D funding and growing initiatives in synthetic biology
• Decline in the cost of DNA sequencing and synthesizing
• Environmental concerns and rising demand for fuel alternatives

Restraints

• Environmental impact of genetically engineered microbes

Opportunities

• Increasing investments by major market players
• Technological advancements in synthetic biology

Challenges

• Over-use of synthetically developed and designed organisms and machines in a world otherwise mostly natural

Companies Mentioned

• Agilent Technologies, Inc.
• Amyris, Inc.
• Arzeda
• Atum
• Business Overview
• Codexis, Inc.
• Creative Enzymes
• Cyrus Biotechnology, Inc.
• Eurofins Scientific
• Genscript Biotech Corporation
• Ginkgo Bioworks
• Integrated Dna Technologies, Inc.
• Intrexon Corporation
• Merck Kgaa
• New England Biolabs
• Novozymes A/S
• Synthego Corporation
• Synthetic Genomics, Inc. (SGI)
• Teselagen
• Thermo Fisher Scientific, Inc.
• Twist Bioscience

For more information about this report visit https://www.researchandmarkets.com/r/qz65qi